Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-β in experimental mesangioproliferative glomerulonephritis

American Journal of Kidney Diseases

Volumn 31, Issue 3, 1998, Pages 453-463

  Zoja, Carla ^b   Scid, Biol ^c   Abbate, Mauro ^c   Corna, Daniela ^c   Capitanio, Matteo ^c   Donadelli, Roberta ^c   Bruzzi, Isabella ^c   Oldroyd, Simon ^a   Benigni, Ariela ^c   Remuzzi, Giuseppe ^c  

^a European Community Program Human Capital and Mobility   (Belgium)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c NONE

Author keywords

Angiotensin II inhibitors; Anti Thy 1 glomerulonephritis; TGF

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM; NONHUMAN; RAT;

EID: 0031889815     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v31.pm9506682     Document Type: Article

References (63)

1. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
2. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85:541-549, 1990
3. Remuzzi A, Benigni A, Malanchini B, Bruzzi I, Foglieni C, Remuzzi G: ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats. Kidney Int 47:1319-1326, 1995
4. Zoja C, Remuzzi A, Corna D, Perico N, Bertani T, Remuzzi G: Renal protective effect of angiotensin-converting enzyme inhibition in aging rats. Am J Med 92:60S-63S, 1992(suppl 4B)
5. Anderson S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36:526-536, 1989
6. Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 2:220-228, 1994
7. Zoja C, Coma D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A: Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 4:213-221, 1996
8. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537-543, 1994
9. Ruiz-Ortega M, Gonzalez E, Ortiz A, Egido J: ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48:1778-1791, 1995
10. Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
11. Kamper AL, Straudgaard S, Leyssac PP: Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 5:423-430, 1992
12. Hannedouche T, Landais P, Goldfarb B, El Esper N, Fournier A, Godin M, Durand D, Chanard J, Mignon F, Suo JM: Randomized controlled trial of enalapril and β blockers in non-diabetic chronic renal failure. BMJ 309:833-837, 1994
13. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90:766-771, 1992
14. Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ: Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 267:657-663, 1993
15. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short-and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
16. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 4:19-25, 1996
17. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The reno-protective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29:254-264, 1997
18. Meyer TW, Anderson S, Rennke HG, Brenner BM: Reversing glomerular hypertension stabilizes established glomerular injury. Kidney Int 31:752-759, 1987
19. Morelli E, Loon NR, Meyer TW, Peters W, Myers BD: Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39:76-82, 1990
20. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 6:36-43, 1993
21. Wolf G, Haberstroh U, Neilson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
22. Ray PE, Aguilera G, Kopp JB, Horikoshi S, Klotman PE: Angiotensin II receptor-mediated proliferation of cultured human fetal mesangial cells. Kidney Int 40:764-771, 1991
23. Abboud HE: Role of platelet-derived growth factor in renal injury. Annu Rev Physiol 57:297-309, 1995
24. Moriyama T, Fujibayashi M, Fujiwara Y, Kaneko T, Xia C, Imai E, Kamada T, Ando A, Ueda N: Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells. J Am Soc Nephrol 6:95-101, 1995
25. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
26. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
27. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
28. Wiseman DM, Polverini PJ, Kamp DW, Leibovich SJ: Transforming growth factor-beta (TGF-β) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem Biophys Res Commun 157:793-800, 1988
29. Yamamoto T, Wilson CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 32:514-525, 1987
30. Floege J, Eng E, Young BA, Johnson RJ: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 43:S-47-S-54, 1993 (suppl 39)
31. Johnson RJ, Garcia RL, Pritzl P, Alpers CE: Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat. Am J Pathol 136:369-374, 1990
32. Bagchus WM, Hoedmaeker PJ, Rozing J, Bakker WW: Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. Lab Invest 55:680-687, 1986
33. Yamamoto T, Yamamoto K, Kawasaki K, Yaoita E, Shimizu F, Kihara I: Immunoelectron microscopic demonstration of Thy-1 antigen on the surfaces of mesangial cells in the rat glomerulus. Nephron 43:293-298, 1986
34. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
35. Border WA, Okuda S, Languino L, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
36. Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ: In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J Pharmacol Exp Ther 262:139-144, 1992
37. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78:957-962, 1971
38. Read SM, Northcote DH: Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116:53-64, 1981
39. Bravo R, Frank R, Blundell PA, MacDonald BH: Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 326:515-517, 1987
40. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 166:209-219, 1986
41. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589-599, 1985
42. Rambaldi A, Young DC, Griffin ID: Expression of the M-CSF (CSF-1) gene by human monocytes. Blood 69:1409-1413, 1987
43. Feinberg AP, Volgestein B : A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
44. Fort P, Marty L, Piechaczyk M, el-Sabrouty S, Dani C, Jeanteur P, Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde 3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13:1431-1442, 1985
45. Benigni A, Perico N, Gaspari F, Zoja C, Bellizzi L, Gabanelli M, Remuzzi G: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 260:F331-F339, 1991
46. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ: Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol 147:1715-1727, 1995
47. Yamamoto T, Mundy CA, Wilson CB, Blantz RC: Effect of mesangial cell lysis and proliferation on glomerular hemodynamics in the rat. Kidney Int 40:705-713, 1991
48. Kiyama S, Nanishi F, Tomooka S, Okuda S, Onoyama K, Fujishima M: Inhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum (ATS)-induced mesangiolysis in spontaneously hypertensive rats. Life Sci 54:1891-1900, 1994
49. Kohno M, Horio T, Ikeda M, Yokokawa K, Fukui T, Yasunari K, Kurihara N, Takeda T: Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int 42:860-866, 1992
50. Neuwirth R, Satriano JA, DeCandido S, Clay K, Schlondorff D: Angiotensin II causes formation of platelet activating factor in cultured rat mesangial cells. Circ Res 64:1224-1229, 1989
51. Haberstroh U, Zahner G, Disser M, Thaiss F, Wolf G, Stahl RAK: TGF-β stimulates rat mesangial cell proliferation in culture: Role of PDGF β-receptor expression. Am J Physiol 264:F199-F205, 1993
52. Stouffer GA, Owens GK: TGF-β promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest 93:2048-2055, 1994
53. Roberts AB, McCune BK, Sporn MB: TGF-β: Regulation of extracellular matrix. Kidney Int 41:557-559, 1992
54. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372, 1993
55. Border WA, Noble NA, Jamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
56. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N, Imai E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
57. Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ: Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A 88:6560-6564, 1991
58. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
59. Yoshimura A, Iwasaki S, Inui K, Ideura T, Koshikawa S, Yanagisawa M, Masaki T: Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int 48:1290-1297, 1995
60. Fukuda K, Yanagida T, Okuda S, Tamaki K, Ando T, Fujishima M: Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney Int 49:1320-1329, 1996
61. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 44:1036-1047, 1993
62. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen UM, Stahl RAK: Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 51:770-776, 1997
63. Ruiz-Ortega M, Bustos C, Gonzalez-Cuadrado S, Hernandez-Presa MA, Egido J: Angiotensin II (AngII) participates in mononuclear cell recruitment in the kidney through nuclear factor-kappa B (NF-kB) activation and monocyte chemoattractant protein-1 (MCP-1) gene expression. J Am Soc Nephrol 7:1718, 1996 (abstr)